Table 3.

Overall results in adult T-LBL

TotalStage I/IIStage III/IV
Evaluable 45 12 33 
CR 42  (93%) 12  (100%) 30  (91%) 
 After induction 34  (83%) 9  (83%) 25  (84%) 
 After salvage 7  (17%)3-150 2  (17%)3-150 5  (16%)  
Failure 2  (5%) 0 2  (6%)  
Early death 1  (2%) 0 1  (3%)  
Relapse 15  (36%)3-151 4  (33%) 11  (37%)3-151 
Death in CR 2  (5%) 0 2  (7%)  
CCR 25  (59%)3-152 8  (67%) 17  (57%)3-152 
TotalStage I/IIStage III/IV
Evaluable 45 12 33 
CR 42  (93%) 12  (100%) 30  (91%) 
 After induction 34  (83%) 9  (83%) 25  (84%) 
 After salvage 7  (17%)3-150 2  (17%)3-150 5  (16%)  
Failure 2  (5%) 0 2  (6%)  
Early death 1  (2%) 0 1  (3%)  
Relapse 15  (36%)3-151 4  (33%) 11  (37%)3-151 
Death in CR 2  (5%) 0 2  (7%)  
CCR 25  (59%)3-152 8  (67%) 17  (57%)3-152 
F3-150

One patient first evaluated before reinduction.

F3-151

One relapse after stem cell transplantation (SCT).

F3-152

One CCR after SCT.

T-LBL indicates T-lymphoblastic leukemia; CR, complete remission; CCR, continuous complete remission.

View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal